Literature DB >> 10731620

Nicotinic receptors in the brain. Links between molecular biology and behavior.

M R Picciotto1, B J Caldarone, S L King, V Zachariou.   

Abstract

Molecular cloning has elucidated the sequence of a family of acetylcholine receptor subunits that are activated by nicotine. Subsequent studies on the localization of individual subunits and the physiological properties of nicotinic subunit combinations in vitro, have led to identification of subunit compositions of nicotinic receptors that may function in vivo, as the native receptor. A particular challenge for the field has been to use these molecular data to determine which individual nicotinic receptor subtype is responsible for mediating each of the behavioral effects of nicotine. Human and animal studies have shown that nicotine is reinforcing and likely responsible for the addictive properties of tobacco. In addition, nicotine has been shown to have effects on locomotion, cognition, affect, and pain sensitivity. Recent studies combining the techniques of molecular biology, pharmacology, electrophysiology, and behavioral analysis to analyze knock out mice that lack individual subunits of the nicotinic acetylcholine receptor, have helped identify the role of specific nicotinic subunits in some of these complex behaviors. These studies could ultimately be useful in designing specific nicotinic receptor agonists and antagonists that may have uses in the clinic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731620     DOI: 10.1016/S0893-133X(99)00146-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  79 in total

Review 1.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

2.  Galantamine in the treatment of minor depression with mild to moderate Alzheimer's dementia in an elderly woman.

Authors:  Kannayiram Alagiakrishnan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

Review 4.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

5.  Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence.

Authors:  Xiang-Yang Lou; Jennie Z Ma; Thomas J Payne; Joke Beuten; Karen M Crew; Ming D Li
Journal:  Hum Genet       Date:  2006-07-28       Impact factor: 4.132

Review 6.  Nicotine and hippocampus-dependent learning: implications for addiction.

Authors:  Thomas J Gould
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

7.  A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.

Authors:  Xiang-Yang Lou; Guo-Bo Chen; Lei Yan; Jennie Z Ma; Jun Zhu; Robert C Elston; Ming D Li
Journal:  Am J Hum Genet       Date:  2007-04-25       Impact factor: 11.025

Review 8.  DNA methylation impacts on learning and memory in aging.

Authors:  Liang Liu; Thomas van Groen; Inga Kadish; Trygve O Tollefsbol
Journal:  Neurobiol Aging       Date:  2007-09-11       Impact factor: 4.673

9.  Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.

Authors:  Pretal P Muldoon; Lois S Akinola; Joel E Schlosburg; Aron H Lichtman; Laura J Sim-Selley; Anu Mahadevan; Benjamin F Cravatt; M Imad Damaj
Journal:  Neuropharmacology       Date:  2020-05-30       Impact factor: 5.250

Review 10.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.